RIBAVIRIN Side Effects

6817347-1 | Alopecia Areata, Alopecia Universalis, Anaemia, Anti-thyroid Antibody Positive
on Jun 17, 2010 Male patient from TURKEY , 57 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia areata, alopecia universalis, anaemia, anti-thyroid antibody positive. Ribavirin dosage: 1000 Mg Daily. During the same period patient was treated with PEGYLATED INTERFERON (100 Ug 1x Week) (View Pegylated Interferon Review and Pegylated Interferon Label ).

6817201-5 | Anaemia, Deep Vein Thrombosis, Pulmonary Embolism
Patient was taking Ribavirin (View Usage). Patient had the following side effects: anaemia, deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?) on Jun 28, 2010 from GERMANY Additional patient health information: Male patient , weighting 231.5 lb, . Ribavirin dosage: . During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

6813626-2 | Cholecystitis
Adverse event was reported on Jun 24, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: BELGIUM , weighting 198.4 lb, After Ribavirin was administered, patient had the following side effects: cholecystitis. During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

6810593-2 | Alopecia Universalis, Anti-thyroid Antibody Positive, Dermatitis, Eczema, Hypothyroidism
on Jun 14, 2010 Female patient from TURKEY , 34 years of age, weighting 136.7 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia universalis, anti-thyroid antibody positive, dermatitis, eczema (What is eczema?), hypothyroidism. Ribavirin dosage: 800 Mg, Daily. During the same period patient was treated with PEGINTERFERON ALFA 2B (1.5 ?g/kg 1x/week Subcutaneous) (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ).


6797583-3 | Decreased Appetite, Escherichia Test Positive, Haemoglobin Decreased, Multi-organ Failure, Neutropenic Colitis, Platelet Count Decreased, Weight Decreased
on Jun 10, 2010 Male patient from KOREA, REPUBLIC OF , 54 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient had the following side effects: decreased appetite, escherichia test positive, haemoglobin decreased, multi-organ failure, neutropenic colitis, platelet count decreased, weight decreased. Ribavirin dosage: 800 Mg, Daily. During the same period patient was treated with PEGINTERFERON ALFA 2A (180 Ug 1x/week) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

6797194-X | Anaemia, Cardiac Failure Congestive, Cardiomyopathy, Conduction Disorder, Dyspnoea Exertional, Ejection Fraction Decreased, Electrocardiogram St Segment Depression, Electrocardiogram T Wave Inversion
Patient was taking Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: anaemia, cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?), conduction disorder, dyspnoea exertional, ejection fraction decreased, electrocardiogram st segment depression, electrocardiogram t wave inversion on Jun 10, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: Df. During the same period patient was treated with PEGYLATED INTEREFERON ALFA (Df) (View Pegylated Intereferon Alfa Review and Pegylated Intereferon Alfa Label ). Patient was hospitalized.

6784438-3 | Cardiac Failure Congestive, Cardiomyopathy, Ejection Fraction Decreased, Left Ventricular Hypertrophy
Adverse event was reported on Jun 10, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: (df)) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 49 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?), ejection fraction decreased, left ventricular hypertrophy. During the same period patient was treated with PEGYLATED INTERFERON ALFA ((df)) (View Pegylated Interferon Alfa Review and Pegylated Interferon Alfa Label ). Patient was hospitalized.

6767716-3 | Alpha 1 Foetoprotein Increased, Anaemia, Bacterial Test Positive, Blood Potassium Decreased, Blood Pressure Decreased, Chest Pain, Computerised Tomogram Abnormal, Cough, Dyspnoea
on Jun 08, 2010 Female patient from UNITED STATES , weighting 112.0 lb, was diagnosed with gastritis, breast cancer (What is breast cancer?) and was treated with Ribavirin (View Usage). Patient had the following side effects: alpha 1 foetoprotein increased, anaemia, bacterial test positive, blood potassium decreased, blood pressure decreased, chest pain (What is chest pain?), computerised tomogram abnormal, cough, dyspnoea. Ribavirin dosage: Last Dose Prior To Sae: 15 Apr 10. During the same period patient was treated with PEGINTERFERON ALFA 2A (Last Dose Prior To Sae: 12 Apr 10. Form: Susp.route: Inj.) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), NEXIUM (View Nexium Review and Nexium Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), FEROSUL (View Ferosul Review and Ferosul Label ). Patient was hospitalized.

6767538-3 | Abortion Spontaneous
on May 24, 2010 Female patient from UNITED STATES , 25 years of age, was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: abortion spontaneous. Ribavirin dosage: .

6766985-3 | Parkinsonism
Patient was taking Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: parkinsonism on Jun 04, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 57 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: . During the same period patient was treated with INTERFERON ALFA 2B (Dose: 3 Mu) (View Interferon Alfa-2b Review and Interferon Alfa-2b Label ).

6763773-9 | Hepatic Failure, Hepatic Neoplasm Malignant, Influenza Like Illness, Parkinsonism
Adverse event was reported on Jun 04, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 52 years of age, Patient had the following side effects: hepatic failure, hepatic neoplasm malignant, influenza like illness, parkinsonism. During the same period patient was treated with INTERFERON ALFA 2B (Dose: 3 Mu Thrice Weekly) (View Interferon Alfa-2b Review and Interferon Alfa-2b Label ), INTERFERON ALFA 2B (Route: Subcutaneous) (View Interferon Alfa-2b Review and Interferon Alfa-2b Label ).

6758411-5 | Anaemia, Chest Pain, Cough, Dyspnoea
on May 25, 2010 Female patient from UNITED STATES , weighting 112.0 lb, was diagnosed with gastritis, breast cancer (What is breast cancer?) and was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: anaemia, chest pain (What is chest pain?), cough, dyspnoea. Ribavirin dosage: Last Dose Prior To Sae: 15 Apr 10. During the same period patient was treated with PEGINTERFERON ALFA 2A (Last Dose Prior To Sae: 12 Apr 10. Form: Susp.route: Inj.) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), NEXIUM (View Nexium Review and Nexium Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), FEROSUL (View Ferosul Review and Ferosul Label ). Patient was hospitalized.

6758383-3 | Abortion Spontaneous, Pregnancy
on May 24, 2010 Female patient from UNITED STATES , 25 years of age, was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, pregnancy (What is pregnancy?). Ribavirin dosage: .

6754761-7 | Abasia, Autoimmune Disorder, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Dizziness, Effusion, Electrocardiogram St Segment Elevation, Illusion, Oedema Peripheral, Pericarditis
Patient was taking Ribavirin (View Usage). Patient had the following side effects: abasia, autoimmune disorder, chronic inflammatory demyelinating polyradiculoneuropathy, dizziness (What is dizziness?), effusion, electrocardiogram st segment elevation, illusion, oedema peripheral, pericarditis on May 19, 2010 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: Po. During the same period patient was treated with INTERFERON (View Interferon Review and Interferon Label ). Patient was hospitalized.

6750079-7 | Cystitis, Headache, Meningitis, Neck Pain
Adverse event was reported on May 27, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: 3 Caps -600mg-twice Daily Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 191.0 lb, After Ribavirin was administered, patient had the following side effects: cystitis, headache (What is headache?), meningitis (What is meningitis?), neck pain. During the same period patient was treated with PEGASYS (180mcg Every Week Sq) (View Pegasys Review and Pegasys Label ), DIOVAN (View Diovan Review and Diovan Label ), CRESTOR (View Crestor Review and Crestor Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6749408-X | Anaemia, Jaundice, No Adverse Event, Virologic Failure
on May 24, 2010 Female patient from GERMANY , 62 years of age, was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, jaundice (What is jaundice?), no adverse event, virologic failure. Ribavirin dosage: Dose: Weight Based. During the same period patient was treated with PEGINTERFERON ALFA 2B (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ).

6749385-1 | Jaundice
on May 24, 2010 Male patient from GERMANY , 22 years of age, was treated with Ribavirin (View Usage). Patient had the following side effects: jaundice (What is jaundice?). Ribavirin dosage: Dose: Weight Based. During the same period patient was treated with PEGINTERFERON ALFA 2B (Dose: 1ug/o.i.w., Dose Weight Based) (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ), PEGINTERFERON ALFA 2B (Dose Reduced Between Week 8-13) (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ), PEGINTERFERON ALFA 2B (Dose Reduced Between Week 22-24) (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ).

6745660-5 | Cholecystitis Acute, Confusional State, Pyrexia
Patient was taking Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: cholecystitis acute, confusional state, pyrexia on May 14, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: 1000mg, Qd, Oral. During the same period patient was treated with PEGASYS (180 Ug, Weekly, Sc) (View Pegasys Review and Pegasys Label ), IDX184 (Qd- Oral) (View Idx184 Review and Idx184 Label ), WELCHOL (View Welchol Review and Welchol Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), RESTORIL (View Restoril Review and Restoril Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

6745163-8 | Abasia, Arthropod Bite, Cryoglobulinaemia, Oedema Peripheral, Rash, Skin Exfoliation, Vascular Rupture
Adverse event was reported on May 18, 2010 by a Female patient taking Ribavirin (View Usage) (Dosage: Po) was diagnosed with hepatitis c (What is hepatitis c?), vasculitis (What is vasculitis?) and. Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: abasia, arthropod bite, cryoglobulinaemia, oedema peripheral, rash (What is rash?), skin exfoliation, vascular rupture. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6745137-7 | Abortion Spontaneous, Pregnancy Of Partner
on May 10, 2010 Female patient from UNITED STATES , 25 years of age, was treated with Ribavirin (View Usage). Patient had the following side effects: abortion spontaneous, pregnancy of partner. Ribavirin dosage: (df). During the same period patient was treated with PEGASYS ((df)) (View Pegasys Review and Pegasys Label ).

6733941-0 | Anaemia, Deep Vein Thrombosis, Pulmonary Embolism
on May 10, 2010 Male patient from GERMANY , weighting 231.5 lb, was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: anaemia, deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Ribavirin dosage: . During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

6732585-4 | Abdominal Distension, Abdominal Pain, Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Coeliac Disease, Lethargy, Nausea
Patient was taking Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, coeliac disease, lethargy, nausea (What is nausea?) on May 06, 2010 from AUSTRALIA Additional patient health information: Female patient , 45 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: 400 Mg; Bid;. During the same period patient was treated with PEGINTERFERON ALFA 2A (180 Mcg; Qw; Sc, 90 Mcg; Qw; Sc) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ).

6725600-5 | Alcohol Use
Adverse event was reported on Apr 29, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: ) . Location: GERMANY , weighting 187.4 lb, Patient had the following side effects: alcohol use. During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

6725525-5 | Congenital Central Nervous System Anomaly, Meningocele, Small For Dates Baby
on Mar 18, 2010 Female patient from UNITED STATES , weighting 2.65 lb, was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: congenital central nervous system anomaly, meningocele, small for dates baby. Ribavirin dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), TAKEPRON (View Takepron Review and Takepron Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), DOMPERIDON (View Domperidon Review and Domperidon Label ), HIRUDOID (Hirdoid Soft) (View Hirudoid Review and Hirudoid Label ), RESTAMIN (View Restamin Review and Restamin Label ).

6722815-7 | Dyspnoea, Fatigue, Haemoglobin Decreased, Hypophagia, Weight Decreased
on May 12, 2010 Male patient from UNITED STATES , weighting 147.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, fatigue, haemoglobin decreased, hypophagia, weight decreased. Ribavirin dosage: 3 Caps - 600mg- Bid Po. During the same period patient was treated with PEGAYSYS 180MCG/.5ML ROCHE (180 Mcg Once A Week Sq) (View Pegaysys 180mcg/.5ml Roche Review and Pegaysys 180mcg/.5ml Roche Label ), VITAMIN C (View Vitamin C Review and Vitamin C Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), ADVIL (View Advil Review and Advil Label ), SLOW FE (View Slow Fe Review and Slow Fe Label ).

6722534-7 | Biliary Colic
Patient was taking Ribavirin (View Usage). Patient had the following side effects: biliary colic on May 06, 2010 from ROMANIA Additional patient health information: Female patient , weighting 119.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: Dose: 1000, Frequency: Daily, Stopped Between 01 May And 05 May 2010. During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

6721797-1 | Dermatitis Herpetiformis
Adverse event was reported on May 04, 2010 by a Female patient taking Ribavirin (View Usage) (Dosage: ) . Location: FRANCE , 52 years of age, After Ribavirin was administered, patient had the following side effects: dermatitis herpetiformis. During the same period patient was treated with INTERFERON ALFA 2B (3 X 3 Mu Weekly) (View Interferon Alfa-2b Review and Interferon Alfa-2b Label ).

6719242-5 | Blood Urine Present, Gingival Bleeding, Haematochezia, Haemorrhage, Idiopathic Thrombocytopenic Purpura
on May 10, 2010 Male patient from UNITED STATES , 50 years of age, weighting 153.9 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: blood urine present, gingival bleeding, haematochezia, haemorrhage, idiopathic thrombocytopenic purpura. Ribavirin dosage: . Patient was hospitalized.

6717631-6 | Dizziness, Gait Disturbance, Lip Dry, Lip Pain, Lip Swelling, Secretion Discharge
on May 07, 2010 Male patient from UNITED STATES , weighting 170.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient had the following side effects: dizziness (What is dizziness?), gait disturbance, lip dry, lip pain, lip swelling, secretion discharge. Ribavirin dosage: 3 Capsules Am + Pm Po. During the same period patient was treated with PEG INTRON (120mcg Once Weekly Sq) (View Peg-intron Review and Peg-intron Label ).

6717439-1 | Deep Vein Thrombosis
Patient was taking Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?) on Apr 27, 2010 from GERMANY Additional patient health information: Female patient , weighting 149.9 lb, . Ribavirin dosage: . During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ).

6711588-X | Economic Problem, Presyncope, Visual Impairment
Adverse event was reported on May 04, 2010 by a Female patient taking Ribavirin (View Usage) (Dosage: 2 Caps -400mg- Bid Po) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 117.0 lb, Patient experienced the following unwanted or unexpected effects: economic problem, presyncope, visual impairment. During the same period patient was treated with PEGASYS (180mcg Once A Week Sq) (View Pegasys Review and Pegasys Label ), LORCET HD (View Lorcet-hd Review and Lorcet-hd Label ), XANAX (View Xanax Review and Xanax Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), LIDODERM (View Lidoderm Review and Lidoderm Label ), BONIVA (View Boniva Review and Boniva Label ).

6700098-1 | Pruritus, Sunburn
on Apr 27, 2010 Female patient from UNITED STATES , 64 years of age, was diagnosed with hepatitis (What is hepatitis?) and was treated with Ribavirin (View Usage). Patient had the following side effects: pruritus, sunburn. Ribavirin dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ).

6695757-3 | Disease Recurrence, Haematochezia, Kidney Infection, Pharyngitis, Platelet Count Decreased
on Apr 23, 2010 Male patient from UNITED STATES , weighting 165.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: disease recurrence, haematochezia, kidney infection, pharyngitis, platelet count decreased. Ribavirin dosage: 600mg Twice A Day Po. During the same period patient was treated with PEGASYS (.5 Ml Once A Week Sq) (View Pegasys Review and Pegasys Label ), VENTOLIN DS (View Ventolin Ds Review and Ventolin Ds Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), TYLENOL ES (View Tylenol Es Review and Tylenol Es Label ), NADOLOL (View Nadolol Review and Nadolol Label ).

6688771-5 | Choroidal Detachment, Meningeal Disorder, Ocular Vasculitis, Retinal Detachment, Uveitis, Vogt-koyanagi-harada Syndrome
Patient was taking Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: choroidal detachment, meningeal disorder, ocular vasculitis, retinal detachment, uveitis, vogt-koyanagi-harada syndrome on Apr 07, 2010 from FRANCE Additional patient health information: Male patient , 35 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: . During the same period patient was treated with INTERFERON ALPHA 2A (INTERFERON ALFA 2A) (View Interferon Alpha 2a (interferon Alfa-2a) Review and Interferon Alpha 2a (interferon Alfa-2a) Label ).

6688284-0 | Neoplasm Malignant
Adverse event was reported on Mar 24, 2010 by a Female patient taking Ribavirin (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: SPAIN , 38 years of age, Patient had the following side effects: neoplasm malignant. During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ).

6673279-3 | Small For Dates Baby
on Mar 18, 2010 Male patient from UNITED STATES , weighting 3.09 lb, was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: small for dates baby. Ribavirin dosage: . During the same period patient was treated with PEG INTRON (Dose: 1.5 Ug/kg) (View Peg-intron Review and Peg-intron Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), DOMPERIDON (View Domperidon Review and Domperidon Label ), HEPARIN (View Heparin Review and Heparin Label ), RESTAMIN (View Restamin Review and Restamin Label ).

6672054-3 | Aneurysm, Eye Haemorrhage, Retinal Exudates, Retinal Vein Occlusion, Retinopathy, Scotoma, Visual Field Defect
on Mar 22, 2010 Male patient from FRANCE , 50 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: aneurysm (What is aneurysm?), eye haemorrhage, retinal exudates, retinal vein occlusion, retinopathy, scotoma, visual field defect. Ribavirin dosage: . During the same period patient was treated with PEGINTERFERON ALFA 2B (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ).

6671815-4 | Cerebral Ventricle Dilatation, Meningocele, Small For Dates Baby
Patient was taking Ribavirin (View Usage). Patient had the following side effects: cerebral ventricle dilatation, meningocele, small for dates baby on Mar 18, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 2.65 lb, . Ribavirin dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), DOMPERIDON (View Domperidon Review and Domperidon Label ), HIRUDOID (Hirdoid Soft) (View Hirudoid Review and Hirudoid Label ), RESTAMIN (View Restamin Review and Restamin Label ).

6668684-5 | Anaemia, Cardiac Failure Congestive, Hepatitis C Rna Positive, Interstitial Lung Disease, Product Quality Issue, Pulmonary Toxicity, Restrictive Pulmonary Disease, Therapeutic Response Decreased
Adverse event was reported on Mar 08, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: 800 Mg Oral; Oral) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: TURKEY , 68 years of age, After Ribavirin was administered, patient had the following side effects: anaemia, cardiac failure congestive, hepatitis c rna positive, interstitial lung disease, product quality issue, pulmonary toxicity, restrictive pulmonary disease, therapeutic response decreased.

6663689-2 | Neoplasm Malignant
on Mar 24, 2010 Female patient from SPAIN , 38 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: neoplasm malignant. Ribavirin dosage: . During the same period patient was treated with PEG INTERFERON ALFA 2A (RO 25 8310) (View Peg-interferon Alfa 2a (ro 25-8310) Review and Peg-interferon Alfa 2a (ro 25-8310) Label ).

6657726-9 | Dry Skin, Pruritus, Rash, Tachycardia
on Jan 06, 2009 Male patient from UNITED STATES , 49 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient had the following side effects: dry skin, pruritus, rash (What is rash?), tachycardia. Ribavirin dosage: 800 Mg; Po. During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ). Patient was hospitalized.

6657556-8 | Abortion Spontaneous
Patient was taking Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: abortion spontaneous on May 19, 2009 from UNITED STATES Additional patient health information: Female patient , 38 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: ;qd;. During the same period patient was treated with PEGINTERFERON ALFA 2B (;qw;) (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ).

6655174-9 | Retinal Haemorrhage
Adverse event was reported on Mar 15, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: ) . Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: retinal haemorrhage.

6650431-4 | Anaemia, Hyperbilirubinaemia, Jaundice
on Mar 05, 2010 Female patient from GERMANY , 62 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient had the following side effects: anaemia, hyperbilirubinaemia, jaundice (What is jaundice?). Ribavirin dosage: 1000mg-qd. During the same period patient was treated with PEG IFN ALFA 2B (View Peg-ifn-alfa 2b Review and Peg-ifn-alfa 2b Label ).

6650389-8 | Lichenoid Keratosis, Skin Oedema
on Mar 09, 2010 Female patient from TUNISIA , 64 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: lichenoid keratosis, skin oedema. Ribavirin dosage: (1 Df 1x/week). During the same period patient was treated with INTRON A ((1 Df 1x/week)) (View Intron A Review and Intron A Label ).

6650299-6 | Vogt-koyanagi-harada Syndrome
Patient was taking Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: vogt-koyanagi-harada syndrome on Mar 05, 2010 from SAUDI ARABIA Additional patient health information: Male patient , 30 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: . During the same period patient was treated with INTERFERON ALPHA 2B (View Interferon-alpha 2b Review and Interferon-alpha 2b Label ).

6650272-8 | Cardiac Failure Congestive, Dyspnoea Exertional, Interstitial Lung Disease, Restrictive Pulmonary Disease
Adverse event was reported on Mar 05, 2010 by a Male patient taking Ribavirin (View Usage) (Dosage: 800mg-qd-oral) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: TURKEY , 68 years of age, Patient had the following side effects: cardiac failure congestive, dyspnoea exertional, interstitial lung disease, restrictive pulmonary disease. During the same period patient was treated with PEGINTERFERON ALFA 2A (100mcg-weekly-subcutane) (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ).

6650270-4 | Arthralgia, Haemolytic Anaemia, Hyperbilirubinaemia, Influenza Like Illness, Leukopenia
on Mar 05, 2010 Male patient from GERMANY , 22 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). After Ribavirin was administered, patient had the following side effects: arthralgia, haemolytic anaemia, hyperbilirubinaemia, influenza like illness, leukopenia. Ribavirin dosage: 1000mg-qd. During the same period patient was treated with PEG INTRON (1.0ug/oiw) (View Peg-intron Review and Peg-intron Label ).

6649779-9 | Abasia, Cryoglobulinaemia, Oedema Peripheral, Rash, Skin Exfoliation, Vascular Rupture
on Mar 09, 2010 Female patient from UNITED STATES , 50 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Ribavirin (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, cryoglobulinaemia, oedema peripheral, rash (What is rash?), skin exfoliation, vascular rupture. Ribavirin dosage: Po. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

6648953-5 | Anaemia, Hypoxia, Interstitial Lung Disease, Treatment Failure
Patient was taking Ribavirin (View Usage). Patient had the following side effects: anaemia, hypoxia, interstitial lung disease, treatment failure on Mar 08, 2010 from TURKEY Additional patient health information: Male patient , 68 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Ribavirin dosage: (800 Mg, Per Day [then Lowered To 600 Mg/day] Oral. During the same period patient was treated with PEGINTERFERON ALFA 2A (PEGYLATED INTERFERON ALPHA 2A) ((100 Ug 1x/week Subcutaneous)) (View Peginterferon Alfa-2a (pegylated Interferon Alpha-2a) Review and Peginterferon Alfa-2a (pegylated Interferon Alpha-2a) Label ).